Treatment of Hereditary Epidermolysis Bullosa: Updates and Future Prospects

Chao-Kai Hsu; Sheng-Pei Wang; Julia Yu-Yun Lee; John A. McGrath


Am J Clin Dermatol. 2014;15(1):1-6. 

In This Article

9 Conclusion

Collectively, the recent data on animal models and initial clinical trials have raised significant hope of developing new and effective therapies for EB. Although the promise of a cure is still elusive, it is evident that several diseasemodifying treatments are emerging and, with further refinement and additional clinical trials, translational research in EB is making a difference and gradually changing lives for the better. The lessons learned in treating RDEB are likely to have significant implications for improving the management of other forms of EB and indeed other genetic diseases.